CSPIA
BNTX icon

Cary Street Partners Investment Advisory’s BioNTech BNTX Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,711
Closed -$186K – 769
2023
Q3 		$186K Buy
1,711
+111
+7% +$12.3K 0.01% 571
2023
Q2 		$173K Buy
+1,600
New +$180K 0.01% 547

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Cary Street Partners Investment Advisory's BNTX Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 1,711 shares — an estimated $186K sold.

Cary Street Partners Investment Advisory first reported a position in BNTX in Q2 2023 and held it in 2 quarters. The position peaked at $186K in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,711 BioNTech shares in Q4 2023, an estimated $186K.
  • Cary Street Partners Investment Advisory first reported a position in BioNTech in Q2 2023 and held it in 2 quarters.
  • Cary Street Partners Investment Advisory's BioNTech position peaked at $186K in Q3 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.